MacroGenics Inc (NASDAQ:MGNX)
| 25.30 BATS BZX Real-Time Price As of 2:45pm ET |  -0.17 / -0.67%Today’s Change | 18.16 Today|||52-Week Range 36.48 | +10.67% Year-to-Date |
Latest MGNX News | Press Releases
| MacroGenics (MGNX) May Report Negative Earnings: Know the Trend Ahead of Q2 Release Jul 22 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 25.47 |
| Today’s open | 25.54 |
| Day’s range | 24.79 - 25.54 |
| Volume | 12,939 |
| Average volume (3 months) | 765,210 |
| Market cap | $1.5B |
Data as of 2:45pm ET, 07/27/2021
Growth & Valuation
| Earnings growth (last year) | +21.65% |
| Earnings growth (this year) | +4.71% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +63.40% |
| P/E ratio | NM |
| Price/Sales | 11.43 |
| Price/Book | 4.90 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ZYMEZymeworks Inc | +0.61 | +1.82% |
| ---- | ||
| ---- | ||
| AMRXAmneal Pharmaceutica... | -0.01 | -0.21% |
Data as of 2:46pm ET, 07/27/2021
Financials
| Next reporting date | July 30, 2021 |
| EPS forecast (this quarter) | -$0.46 |
| Annual revenue (last year) | $104.9M |
| Annual profit (last year) | -$129.7M |
| Net profit margin | -123.70% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Rockville, Maryland |
Forecasts
